A股午評：滬指漲0.17%，元宇宙概念大漲，兩市超3000股上漲
三大指數漲跌不一，滬指午間收漲0.17%報3370點，深成指漲0.13%，創業板指跌0.24%。兩市3116股上漲，1538股下跌，成交額6690億，北上資金淨買入2.7億。
行業板塊多數上漲，上海培育元宇宙新賽道，元宇宙概念應聲大漲，智度股份等多股漲停，消費電子、汽車芯片、MCU芯片等概念大漲靠前，立訊精密漲約8%；通信大數據行程卡查詢時間由14天變為7天，旅遊股全線上漲；白酒、新冠藥、CXO等消費題材表現活躍，復星醫藥漲4%。昨日表現強勁的光伏、鋰電池等賽道股回落，強勢題材釩電池概念大跌，攀鋼釩鈦跌8%。
元宇宙概念大漲，智度股份等多股漲停。上海市人民政府辦公廳印發促進綠色低碳產業發展、培育“元宇宙”新賽道、促進智能終端產業高質量發展等行動方案的通知，到2025年，“元宇宙”相關產業規模達到3500億元，帶動全市軟件和信息服務業規模超過15000億元、電子信息製造業規模突破5500億元。
旅遊股集體上漲，西域旅遊漲5.8%。工信部發布公吿稱，根據《新型冠狀病毒肺炎防控方案（第九版）》，即日起“通信行程卡”查詢結果的覆蓋時間範圍由“14天”調整為“7天”。
新冠藥概念大漲，華潤雙鶴漲6%。近日，全球唯一一款獲得包括美國、英國及歐盟等多地區授權的，用於新冠暴露前預防的藥物運抵海南。這款由阿斯利康公司研發的中和抗體Evusheld（恩適得）已完成入境特殊物品審批。儘管尚未在我國上市，但根據“國九條”相關政策，Evusheld可在海南博鰲樂城國際醫療旅遊先行區使用，尚不能使用醫保結算，一次性注射兩針價格為13300元。
東吳證券指，週四股指在賽道板塊齊爆發的帶動下止跌收陽，也激活了市場的賺錢效應。整體兩市繼續保持高位震盪走勢，賽道方向表現強勢，其餘板塊輪動表現。但週四量能並不十分活躍，投資者在操作上還是需注意謹慎追漲，重點把握板塊間的輪動走勢，更多留意績優股的低吸機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
